生醫光電市場－全球產業規模、佔有率、趨勢、機會與預測：按技術、應用、最終用戶、地區和競爭對手分類，2021-2031年

全球生醫光電市場預計將從 2025 年的 679.2 億美元穩定成長到 2031 年的 1,320.6 億美元，複合年成長率達到 11.72%。

生醫光電利用生物系統中的光學技術，並將其應用於醫療和生命科學領域的高級成像、感測和治療應用。這項市場擴張的主要驅動力是慢性病盛行率的上升以及全球對非侵入性診斷方法日益成長的需求。這些方法對於精準的醫療介入至關重要，最終目標是改善患者預後並實現疾病的早期檢測。根據德國機械設備製造業聯合會（VDMA）預測，到2024年，包括醫療技術和生命科學在內的全球光電系統和組件市場規模預計將達到7,690億美元，凸顯了光學技術在這些領域的重要性。儘管市場規模龐大，但由於醫療設備監管環境的嚴格性，生醫光電產業仍面臨許多挑戰。國際衛生機構嚴格的核准流程可能會顯著延遲產品上市並增加研發成本，從而阻礙創新解決方案的快速商業化，並抑制整體市場成長。

市場促進因素

全球生醫光電市場的主要驅動力是慢性病和文明病的日益普遍，這從根本上改變了診斷和治療方法。隨著癌症、心血管疾病和糖尿病等疾病在全球範圍內的不斷增加，醫療保健系統越來越重視早期檢測和持續監測，以降低長期治療成本。生醫光電透過非侵入性光活體組織切片和先進的成像技術提供關鍵解決方案，無需傳統手術即可在細胞層面進行精確分析。美國癌症協會預測，到2025年，將有超過200萬例新增癌症病例，凸顯了對快速、高通量光子診斷能力的需求。同時，利用光學技術縮短患者復原時間和住院時間的微創手術需求不斷成長，也推動了市場發展。醫療專業人員擴大在眼科​​和內視鏡等專業領域使用雷射輔助系統和光學視覺化工具，從而實現更精確、創傷更小、更複雜的手術。這種向微創技術的轉變是這些醫療技術製造商業務擴張的主要驅動力，卡爾蔡司醫療技術股份公司眼科戰略業務部門在其 2024/25 年度報告中銷售額成長 8.5%，達到 17.24 億歐元，以及 Yenoptic生醫光電戰略業務部門在 2025 年上半年銷售額成長 11.1%，達到了 1920 億歐元，這一點證明這2920 億歐元。

市場挑戰

醫療設備嚴格的監管架構對全球生醫光電市場的擴張構成重大障礙。鑑於生醫光電解決方案中光學系統與生物組織之間的複雜相互作用，這些產品必須經過衛生監管機構的嚴格審查，以確保患者安全和療效。這種嚴格的監管導致核准時間延長和合遵循成本高昂，給中小型創新企業，尤其是該領域的企業，帶來了沉重的負擔。認證帶來的經濟負擔阻礙了具有潛在變革意義的技術從研發階段走向商業化，提高了市場進入門檻，抑制了競爭。快速完成這些監管流程的難度減緩了先進診斷工具的普及，直接阻礙了市場成長。這些延誤造成的經濟影響巨大，尤其考慮到依賴這些技術的產業的規模。例如，根據德國機械設備製造業聯合會（VDMA）的報告，到2024年，醫療技術和生命科學領域光電系統和組件的全球市場規模將達到711億美元。在這個關鍵的市場領域，成長受到限制，因為製造商必須將資源用於合規監管，而不是投資於產品開發和市場滲透。

市場趨勢

全球生醫光電市場正因人工智慧 (AI) 和機器學習在即時光學數據分析中的應用而發生巨大變革，顯著提高了內視鏡和顯微鏡等成像技術的精度。直接整合到光學系統中的演算法如今能夠實現組織瞬時分類，使臨床醫生能夠在手術過程中以前所未有的精度識別結腸息肉等異常情況。這種技術融合正在推動舊設備的強勁升級換代。醫療機構越來越傾向於採用具備電腦輔助檢測功能的系統來最大限度地減少診斷錯誤，奧林巴斯的內視鏡解決方案業務就充分體現了這一趨勢。該公司報告稱，截至 2025 年 3 月 31 日的會計年度銷售額成長了 8.4%，這主要得益於其人工智慧驅動的 EVIS X1 系統的普及。同時，超高解析度顯微鏡和多光子顯微鏡的進步和商業化正在改變生命科學研究和藥物發現。這些先進的光學技術使科學家能夠在奈米尺度上觀察細胞結構，並在不使用有毒螢光標記的情況下觀察活體組織深處的動態生物過程。製藥業正加大對高解析度儀器的投資，以支持太空生物學研究並加速治療標靶的檢驗。對這些先進儀器日益成長的需求也反映在主要市場參與企業的表現上。布魯克公司旗下BSI CALID部門（包括分子光譜和顯微鏡業務）在2024年第四季及全年業績中，銷售額成長13.9%，達到10.9億美元，這主要得益於高性能光學解決方案的持續應用。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球生醫光電市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 依技術（體外、體內）
  • 應用領域（透射成像、顯微鏡、內部成像、分子光譜、分析感測、光療、表面成像、生物感測器）
  • 依最終使用者分類（檢驗/零件、醫療、醫療診斷、非醫療應用）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美生醫光電市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲生醫光電市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太生物生醫光電市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東與非洲生醫光電市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲生醫光電市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布

第13章：全球生醫光電市場：SWOT分析

第14章：波特五力分析

• 產業內部競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Thermo Fisher Scientific Inc
• Nu Skin Enterprises Inc
• Becton Dickinson & Co
• Glenbrook Technologies Inc
• HAMAMATSU PHOTONICS KK
• Olympus Corp
• Carl Zeiss AG
• Oxford Instruments PLC
• ZENALUX BIOMEDICAL, INC.
• PerkinElmer Health Sciences Inc

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Biophotonics Market is anticipated to grow robustly from USD 67.92 billion in 2025 to USD 132.06 billion by 2031, achieving an 11.72% CAGR. Biophotonics leverages optical technologies within biological systems for advanced imaging, sensing, and therapeutic applications across healthcare and life sciences. This market expansion is primarily propelled by the increasing prevalence of chronic diseases and a heightened global demand for noninvasive diagnostic procedures, which are crucial for precise medical interventions and ultimately aim for improved patient outcomes and earlier disease detection.According to the VDMA, in 2024, the broader global market for photonics systems and components, encompassing medical technology and life sciences, reached a substantial volume of $769 billion, highlighting the foundational importance of optical technologies in these sectors. Despite this significant scale, the biophotonics industry faces a notable challenge from the stringent regulatory landscape governing medical devices. Rigorous approval processes imposed by international health authorities can considerably delay product launches and inflate development costs, thereby complicating the rapid commercialization of innovative solutions and potentially restricting overall market expansion.

Market Driver

A key driver for the Global Biophotonics Market is the rising incidence of chronic and lifestyle-associated diseases, which is fundamentally reshaping diagnostic and therapeutic approaches. With the escalating global prevalence of conditions like cancer, cardiovascular disorders, and diabetes, healthcare systems are increasingly focused on early detection and ongoing monitoring to reduce long-term treatment expenses. Biophotonics provides crucial solutions through non-invasive optical biopsy and advanced imaging techniques, enabling precise cellular-level analysis without traditional surgical interventions, a need underscored by the American Cancer Society's projection of over 2 million new cancer diagnoses in the U.S. in 2025, emphasizing the demand for rapid, high-throughput photonic diagnostic capabilities.Simultaneously, the market is boosted by the growing demand for minimally invasive surgical procedures, which harness light-based technologies to shorten patient recovery periods and hospital stays. Medical professionals are increasingly employing laser-assisted systems and optical visualization tools in specialties such as ophthalmology and endoscopy, allowing for more precise and less traumatic complex interventions. This move towards less invasive methods fuels significant commercial expansion for manufacturers of these medical technologies, as evidenced by Carl Zeiss Meditec AG's Ophthalmology Strategic Business Unit's 8.5% revenue increase to 1,724 million euros in their 2024/25 Annual Report, and Jenoptik's Biophotonics Strategic Business Unit's 11.1% revenue growth to 119.2 million euros in the first half of 2025.

Market Challenge

The stringent regulatory framework governing medical devices poses a significant obstacle to the global biophotonics market's expansion. Given the complex interplay between optical systems and biological tissues in biophotonics solutions, these products undergo rigorous scrutiny by health authorities to guarantee patient safety and effectiveness. This rigorous oversight results in extended approval timelines and substantial compliance expenses, which particularly burden smaller, innovative companies within the sector, often preventing potentially transformative technologies from advancing from research to commercialization due to the financial demands of certification, thus creating a high barrier to market entry and stifling competition.The difficulty in rapidly navigating these regulatory channels directly hampers market growth by delaying the introduction of advanced diagnostic tools. The financial implications of such delays are considerable, especially when considering the sheer scale of the sector that depends on these technologies. For instance, the VDMA reported that in 2024, the global market for photonics systems and components within the medical technology and life science sector alone was valued at $71.1 billion. This significant market segment experiences constrained growth as manufacturers must allocate resources towards regulatory compliance rather than investing in product development and broader market penetration.

Market Trends

The Global Biophotonics Market is being profoundly reshaped by the integration of Artificial Intelligence and Machine Learning for real-time optical data analysis, significantly improving the diagnostic accuracy of imaging techniques such as endoscopy and microscopy. Algorithms now directly incorporated into optical systems can instantly classify tissues, enabling clinicians to identify abnormalities, such as colorectal polyps, with unparalleled precision during procedures. This technological convergence is fueling a strong replacement cycle for older equipment, as healthcare providers increasingly favor systems that offer computer-aided detection to minimize diagnostic errors, a trend exemplified by Olympus Corporation's Endoscopic Solutions business, which reported an 8.4% revenue increase in their fiscal year ended March 31, 2025, largely due to the adoption of their AI-driven EVIS X1 system.Concurrently, the advancements and commercialization of super-resolution and multiphoton microscopy are transforming life sciences research and drug discovery. These advanced optical methods allow scientists to visualize cellular structures at the nanometer scale and observe dynamic biological processes deep within living tissues without the use of toxic fluorescent labels. The pharmaceutical industry is increasingly investing in these high-resolution instruments to support spatial biology studies and expedite the validation of therapeutic targets. This rising demand for sophisticated instrumentation is reflected in the financial results of major market participants, with Bruker Corporation's BSI CALID segment, encompassing its molecular spectroscopy and microscopy divisions, showing a 13.9% revenue increase to $1.09 billion in their Fourth Quarter and Full Year 2024 Financial Results, driven by the sustained adoption of their high-performance optical solutions.

Key Market Players

• Thermo Fisher Scientific Inc
• Nu Skin Enterprises Inc
• Becton Dickinson & Co
• Glenbrook Technologies Inc
• HAMAMATSU PHOTONICS K.K.
• Olympus Corp
• Carl Zeiss AG
• Oxford Instruments PLC
• ZENALUX BIOMEDICAL, INC.
• PerkinElmer Health Sciences Inc

Report Scope

In this report, the Global Biophotonics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Biophotonics Market, By Technology

• In-Vitro
• In-Vivo

Biophotonics Market, By Application

• See-Through imaging
• Microscopy
• Inside Imaging
• Spectro Molecular
• Analytics Sensing
• Light Therapy
• Surface Imaging
• Biosensors

Biophotonics Market, By End User

• Tests and Components
• Medical Therapeutics
• Medical Diagnostics
• Non-medical Application

Biophotonics Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Biophotonics Market.

Available Customizations:

Global Biophotonics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Biophotonics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Technology (In-Vitro, In-Vivo)
  • 5.2.2. By Application (See-Through imaging, Microscopy, Inside Imaging, Spectro Molecular, Analytics Sensing, Light Therapy, Surface Imaging, Biosensors)
  • 5.2.3. By End User (Tests and Components, Medical Therapeutics, Medical Diagnostics, Non-medical Application)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Biophotonics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Technology
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Biophotonics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Technology
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Biophotonics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Technology
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Biophotonics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Technology
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Biophotonics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Technology
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Biophotonics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Technology
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. France Biophotonics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Technology
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Biophotonics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Technology
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Biophotonics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Technology
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Biophotonics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Technology
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia Pacific Biophotonics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Technology
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Biophotonics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Technology
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. India Biophotonics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Technology
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Biophotonics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Technology
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Biophotonics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Technology
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Biophotonics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Technology
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. Middle East & Africa Biophotonics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Technology
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Biophotonics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Technology
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Biophotonics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Technology
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Biophotonics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Technology
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. South America Biophotonics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Technology
  • 10.2.2. By Application
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Biophotonics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Technology
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Biophotonics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Technology
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Biophotonics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Technology
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Biophotonics Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Thermo Fisher Scientific Inc
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Nu Skin Enterprises Inc
• 15.3. Becton Dickinson & Co
• 15.4. Glenbrook Technologies Inc
• 15.5. HAMAMATSU PHOTONICS K.K.
• 15.6. Olympus Corp
• 15.7. Carl Zeiss AG
• 15.8. Oxford Instruments PLC
• 15.9. ZENALUX BIOMEDICAL, INC.
• 15.10. PerkinElmer Health Sciences Inc

16. Strategic Recommendations

17. About Us & Disclaimer